Davis biotech firm names CEO, reports first-quarter loss of $5.2M
Davis biotech firm Arcadia Biosciences Inc. on Tuesday announced that Raj Ketkar will join the company as president and CEO later this month.
Ketkar will replace Roger Salameh, who has served as interim president and CEO since February, when the company announced the departure of Eric Rey. A company co-founder, Rey went on leave in January to have a stent put in a coronary artery.
On Tuesday, Arcadia said Salameh will take on a new role as chief operating officer.
In its first-quarter earnings report released after the close of stock markets on Tuesday, Arcadia said it lost $5.2 million, down about 10.3 percent from a net loss of $5.8 million in the year-ago period.
Mark Glover: 916-321-1184, @markhglover
This story was originally published May 10, 2016 at 2:39 PM with the headline "Davis biotech firm names CEO, reports first-quarter loss of $5.2M."